HOME >> BIOLOGY >> NEWS
Rescuing injured hearts by enhancing regeneration

Using a two-drug approach, researchers at Children's Hospital Boston have demonstrated that it may be possible to rescue heart function after a heart attack and protect the heart from scarring. Working with rats, they combined an agent that overcomes a natural inhibitor of cell division with a naturally occurring growth factor that encourages blood vessel growth (angiogenesis). Together, these two agents enabled heart-muscle cells to multiply and the heart to regain its function after a simulated myocardial infarction. The study will appear in the October 17 issue of the Proceedings of the National Academy of Sciences (posted online during the week of October 9).

Normally, after a heart attack, the damaged heart muscle cannot grow back and is instead replaced by scar tissue. Excessive scarring can impair the heart's pumping capacity and can lead to life-threatening arrhythmias. Heart-muscle cells (cardiomyocytes) normally cannot replicate in mammals, a major obstacle to regeneration. However, in a paper last year, Felix Engel, PhD, and Mark Keating, MD, in the Department of Cardiology at Children's Hospital Boston, showed that they could coax cardiomyocytes to multiply in a petri dish by inhibiting an enzyme known as p38 MAP kinase, which normally suppresses cardiomyocyte replication. [See: www.childrenshospital.org/newsroom/Site1339/mainpageS1339P1sublevel139.html]

Engel and Keating (Keating is now at the Novartis Institute for BioMedical Research) now build on this finding. They studied 120 rats, some with simulated heart attacks. After the injury, the animals were randomly assigned to receive injections with a p38 MAP kinase inhibitor alone, the angiogenesis stimulator FGF1 alone, both agents together, or saline (placebo) for four weeks. Three months later, rats that had received both FGF1 and the p38 MAP kinase inhibitor had markedly improved h
'"/>

Contact: Anna Gonski
anna.gonski@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
9-Oct-2006


Page: 1 2 3

Related biology news :

1. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
2. Scientists identify key to integrating transplanted nerve cells into injured tissue
3. Interdisciplinary team develops guidelines for treating severely injured patients
4. Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves
5. Weizmann Institute scientists discover how substitutions are made for injured genes
6. Cardio exercise benefits in male vs. female hearts
7. Coarse particulate matter in air may harm hearts of asthma sufferers, UNC study finds
8. Adult stem cells to repair hearts damaged by severe coronary artery disease investigated
9. Newts which regrow their hearts
10. UT Southwestern researchers find gene mutation that leads to broken hearts
11. Adult stem cell research at UB targets damaged hearts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2020)... (PRWEB) , ... March 05, ... ... announces the formation of its Scientific Advisory Board (SAB) comprised of the ... institutions, immune-oncology centers, cell therapy centers, and private industry. Cytonus is a ...
(Date:3/5/2020)... ... March 05, 2020 , ... In September 2016, stem cell ... Test™ is the first, and still only, available technology that provides the cell-specific ... provide information about the number and quality of therapeutic tissue stem cells are ...
(Date:3/4/2020)... ... March 04, 2020 , ... VGXI, Inc., ... it has been nominated as a finalist in the category of Best Contract ... as VGXI expedites manufacturing of a DNA vaccine against the novel coronavirus, COVID-19, ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... , ... March 18, 2020 , ... ... monitor users’ bio signals to provide rapid insight into their perceptions of events. ... have on the other. What if they could measure the level of engagement ...
(Date:3/12/2020)... ... March 12, 2020 , ... With ... (AFM) technology, increases the business investment in Europe by inaugurating a new scientific ... Opening Ceremony of the new Nanoscience Center Europe took place Tuesday, February 18, ...
(Date:3/10/2020)... Tex. (PRWEB) , ... March ... ... a full-service cold chain biopharmaceutical engineering firm, is pleased to announce ... focus is on combination medical device qualification and validation in the biopharmaceutical ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... antibody products and services, today announced the launch of its FleXpress™ high-throughput ... a large number of antibodies at 80 ml scale. All production occurs ...
Breaking Biology Technology:
Cached News: